Redefining Quality of Life: The Future of Patient-Reported Outcomes
Redefining Quality of Life: The Future of Patient-Reported Outcomes

Elizabeth Wulff-Burchfield, MD, a medical oncologist and palliative care physician at University of Kansas Medical Center, joins Katy Beckermann, MD, PhD, Tennessee Oncology, to offer perspective on how digital innovation and patient-driven science are shaping the future of quality-of-life measurement.

From AI-adaptive surveys to real-time, real-life feedback from GU oncology patients at home, this conversation explores how clinicians can better understand and respond to the full cancer experience.

Advertisement

Latest News

18F-Flotufolastat-PET Aids in Detection of Hematologic Malignancy in Patients With mCRPC Treated With 177Lu
18F-Flotufolastat-PET Aids in Detection of Hematologic Malignancy in Patients With mCRPC Treated With 177Lu
Emily MenendezRLT | May 23, 2025
18F-flotufolastat-PET can help determine severe hematologic toxicity in patients with mCRPC who are treated with 177Lu.
Does the Addition of Zoledronic Acid to the Standard Treatment of mHSPC Improve Outcomes?
Does the Addition of Zoledronic Acid to the Standard Treatment of mHSPC Improve Outcomes?
Jessica GangamHSPC | May 22, 2025
Researchers evaluated the addition of zoledronic acid to the standard treatment of enzalutamide and ADT.
CREST Trial Marks New Era for High-Risk NMIBC: Dr. Gordon Brown on IO-BCG Combinations
CREST Trial Marks New Era for High-Risk NMIBC: Dr. Gordon Brown on IO-BCG Combinations
Gordon Brown, DONon-Muscle Invasive Urothelial Carcinoma | May 21, 2025
Dr. Brown breaks down the CREST trial results in high-risk NMIBC, highlighting the benefits of combining sasanlimab with BCG.
TAR-200 in BCG-Unresponsive NMIBC: Dr. Gordon Brown on SunRISe-1 Paradigm-Shifting Results
TAR-200 in BCG-Unresponsive NMIBC: Dr. Gordon Brown on SunRISe-1 Paradigm-Shifting Results
Gordon Brown, DOUrothelial Carcinoma | May 21, 2025
Dr. Brown discusses the latest TAR-200 data from the SunRISe-1 trial in BCG-unresponsive NMIBC, highlighting CR rates.
Disitamab Vedotin Combined With a PD-1 Inhibitor May Improve Survival in Patients With Urothelial Cancer
Disitamab Vedotin Combined With a PD-1 Inhibitor May Improve Survival in Patients With Urothelial Cancer
Jessica GangaAdvanced Urothelial Carcinoma | May 20, 2025
Researchers evaluated the use of disitamab vedotin with toripalimab in improving survival in patients with advanced UC.
Teaching TURBT Over 5G: Integrating XR Headsets Into Urologic Practice
Teaching TURBT Over 5G: Integrating XR Headsets Into Urologic Practice
Evan Kovac, MDProstate Cancer | May 19, 2025
Dr. Evan Kovac speaks about his pioneering work with extended reality display technology in urologic surgery and education.
Reframing Cancer Treatment: Trust, Transparency, and the Human Side of Care
Reframing Cancer Treatment: Trust, Transparency, and the Human Side of Care
Elizabeth Wulff-Burchfield, MDProstate Cancer | May 15, 2025
Drs. Wulff-Burchfield and Beckermann share how they help GU patients make informed, personalized treatment decisions.
The Art of the Consult: Goals, Trade-offs, and Treatment in GU Oncology
The Art of the Consult: Goals, Trade-offs, and Treatment in GU Oncology
Elizabeth Wulff-Burchfield, MDProstate Cancer | May 15, 2025
Drs. Wulff-Burchfield and Beckermann discuss how GU oncologists can build trust and deepen patient connections.
Active Surveillance, MRI Can Aid in the Avoidance of Repeat Biopsies for Patients With Prostate Cancer
Active Surveillance, MRI Can Aid in the Avoidance of Repeat Biopsies for Patients With Prostate Cancer
Emily MenendezProstate Cancer Diagnostics | May 15, 2025
The use of MRI-based monitoring can aid in the avoidance of repeat biopsies, and reduce the chances of undergoing surgery.
Bladder Cancer Without Cystectomy: Dr. Alexandre Zlotta on the Maturation of Trimodality Therapy
Bladder Cancer Without Cystectomy: Dr. Alexandre Zlotta on the Maturation of Trimodality Therapy
Alexandre Zlotta, MDMuscle Invasive Urothelial Carcinoma | May 15, 2025
Dr. Zlotta discusses the current state and future of bladder-sparing therapy in MIBC, including how to best select patients.
Durvalumab Plus BCG May Improve Disease-Free Survival in Patients With NMIBC
Durvalumab Plus BCG May Improve Disease-Free Survival in Patients With NMIBC
Emily MenendezNon-Muscle Invasive Urothelial Carcinoma | May 14, 2025
Adding one year of treatment with durvalumab to BCG can extend the time that patients live without disease recurrence.
SNiP-RCC Study: Using Predictive Model to Determine Nivolumab Therapy for Treating Patients With Advanced RCC
SNiP-RCC Study: Using Predictive Model to Determine Nivolumab Therapy for Treating Patients With Advanced RCC
Jessica GangaAdvanced Renal Cell Carcinoma | May 14, 2025
Machine learning may be a useful tool in predicting renal cell carcinoma tumor response to nivolumab monotherapy.
Advertisement
Advertisement
Editorial Advisory Board
Brian Rini, MD, FASCO
Brian Rini, MD, FASCOEditor | Chief of Clinical Trials at Vanderbilt-Ingram Cancer Center
Thomas Powles, MBBS, MRCP, MD
Thomas Powles, MBBS, MRCP, MDEditor | Director, Barts Cancer Centre at St. Bartholomew's Hospital
Katy Beckermann, MD, PhD
Katy Beckermann, MD, PhDEditor | Medical Director of GU Clinical Research at Tennessee Oncology
Christopher Wallis, MD, PhD, FRCSC
Christopher Wallis, MD, PhD, FRCSCAssistant Professor of Urology | University of Toronto
Akhil Abraham Saji, MD
Akhil Abraham Saji, MDEditor | Urologist at Swedish Health Services
David Ambinder, MD
David Ambinder, MDEditor | Urology Resident at New York Medical College/Westchester Medical Center

The Uromigos Live and Unplugged 2024

The Uromigos Live & Unplugged 2024
The Uromigos Live & Unplugged 2024

The Uromigos Live & Unplugged 2024 took place September 27-29 in Nashville, Tennessee.

This meeting was the third annual in-person event hosted by Thomas Powles, MD, and Brian Rini, MD, FASCO, in partnership with Mashup Media, featuring expert panels and audience discussion around the latest data in genitourinary oncology and vision for the future.

Expert Interviews

Teaching TURBT Over 5G: Integrating XR Headsets Into Urologic Practice
Teaching TURBT Over 5G: Integrating XR Headsets Into Urologic Practice
Evan Kovac, MDProstate Cancer | May 19, 2025
Dr. Evan Kovac speaks about his pioneering work with extended reality display technology in urologic surgery and education.
Bladder Cancer Without Cystectomy: Dr. Alexandre Zlotta on the Maturation of Trimodality Therapy
Bladder Cancer Without Cystectomy: Dr. Alexandre Zlotta on the Maturation of Trimodality Therapy
Alexandre Zlotta, MDMuscle Invasive Urothelial Carcinoma | May 15, 2025
Dr. Zlotta discusses the current state and future of bladder-sparing therapy in MIBC, including how to best select patients.
From VEGF to HIF-2 Targeting Drugs: Dr. James Brugarolas’ Journey to Transforming Kidney Cancer Treatment
From VEGF to HIF-2 Targeting Drugs: Dr. James Brugarolas’ Journey to Transforming Kidney Cancer Treatment
James “Jim” Brugarolas, MD, PhDRenal Cell Carcinoma | April 22, 2025
Dr. Brugarolas reflects on his lab's role in developing HIF-2 inhibitors and his ongoing work to improve patient outcomes.
Bladder-Sparing Innovations in MIBC: Dr. Elizabeth Plimack on the RETAIN Approach and Its Future
Bladder-Sparing Innovations in MIBC: Dr. Elizabeth Plimack on the RETAIN Approach and Its Future
Elizabeth Plimack, MD, MS, FASCOMuscle Invasive Urothelial Carcinoma | March 17, 2025
Dr. Plimack details RETAIN, from early findings with neoadjuvant ddMVAC to the evolution of RETAIN-1 and RETAIN-2.
Precision in Prostate Cancer: Dr. Amir Lebastchi on Tailoring Focal Therapy for Optimal Outcomes
Precision in Prostate Cancer: Dr. Amir Lebastchi on Tailoring Focal Therapy for Optimal Outcomes
Akhil Abraham Saji, MDLocalized | January 14, 2025
Drs. Saji and Lebastchi explore focal therapy, covering its historical evolution, techniques, and energy modalities.
Ahmed E. Ghazi – Revolutionizing and Scaling Surgical Training Through Simulation Models
Ahmed E. Ghazi – Revolutionizing and Scaling Surgical Training Through Simulation Models
David Ambinder, MDLocalized | January 6, 2025
Dr. Ghazi is recognized as a pioneer in patient-specific surgical simulation, using state-of-the-art techniques in surgery.

Conference Coverage

Live meeting highlights

CREST Trial Marks New Era for High-Risk NMIBC: Dr. Gordon Brown on IO-BCG Combinations
Gordon Brown, DONon-Muscle Invasive Urothelial Carcinoma | May 21, 2025
Dr. Brown breaks down the CREST trial results in high-risk NMIBC, highlighting the benefits of combining sasanlimab with BCG.
View More
TAR-200 in BCG-Unresponsive NMIBC: Dr. Gordon Brown on SunRISe-1 Paradigm-Shifting Results
Gordon Brown, DOUrothelial Carcinoma | May 21, 2025
Dr. Brown discusses the latest TAR-200 data from the SunRISe-1 trial in BCG-unresponsive NMIBC, highlighting CR rates.
View More
Teaching TURBT Over 5G: Integrating XR Headsets Into Urologic Practice
Evan Kovac, MDProstate Cancer | May 19, 2025
Dr. Evan Kovac speaks about his pioneering work with extended reality display technology in urologic surgery and education.
Read More
Dr. David Canes on WellPrept - Boosting Patient Education and Improving Care
David Canes, MDUrothelial Carcinoma | May 7, 2025
Dr. Canes discusses the formation of the WellPrept delivery platform and how it aims to boost patient education.
View More

Video Insights

Clinical discussions with experts in the field

Network Websites

Blood Cancers Today provides hematologists and oncologists with news, education, and research relevant to their patients and practices. Featuring the latest clinical updates from all facets of the specialty, it offers thought-provoking insights and exclusive interviews from experts in the field.

MashupMD is an innovative medical news and social media aggregator. The platform is optimized to deliver rapid access to the latest headlines in health care and collections of key medical content based on what health care professionals around the world are reading and sharing.

Cancer Nursing Today delivers critical news, research, and commentary to support oncology nurses throughout their education and careers. Its goal is to advance oncology treatments and care practices and promote the nurse’s role in enhanced patient outcomes and quality of life.

DocWire News is a leading source of medical industry news for health care professionals, featuring breaking news, expert commentary, research analysis, and conference highlights. It covers a comprehensive range of clinical specialties, including cardiology, oncology, neurology, and more.

Urban Health Today is the leading independent news source that provides urban health care professionals with relevant research and policy developments that impact patients and their practices. Its coverage focuses on clinical, social, and environmental health disparities.

Powered by DocWire News

GI Oncology Now is the leading medical news resource for practicing oncologists and health care providers treating gastrointestinal malignancies, offering the latest study data and research breakthroughs related to colorectal, gastric, liver, pancreatic, and esophageal cancers.

Heme Today produces the latest news and research for hematologists and oncologists focused on blood disorders such as clotting, red and white blood cell, and iron disorders, including conference highlights, late-breaking research, interviews with leaders in the field, and more.

A medical news property for practicing oncologists treating lung malignancies, Lung Cancers Today features breaking news, commentary, expert interviews, and data analysis to inform providers on the latest research and most effective clinical practices in the lung cancers space.

Nephrology Times delivers the latest news in nephrological treatments and technologies, curating content from clinical trials, conference highlights, and perspectives from key opinion leaders, with the goal of better informing care decisions and improving patient outcomes.

  • 630 Madison Ave.

    Manalapan, NJ 07726

    • About

    About Us

    Contributors and Partners

    Editorial Policy

    Advertising

    Connect

    eNewsletters

    Calendar

    Contact Us

    Contribute

    Our Network

    MashupMD

    Cancer Nursing Today

    Urban Health Today

    Blood Cancers Today

    DocWire News

    © 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.

    Terms of Use | Privacy Policy |